Medtronic plc (ETR:2M6)
Germany · Delayed Price · Currency is EUR | Market Cap | 102.01B |
| Revenue (ttm) | 29.51B |
| Net Income (ttm) | 4.10B |
| Shares Out | n/a |
| EPS (ttm) | 3.18 |
| PE Ratio | 24.86 |
| Forward PE | 16.68 |
| Dividend | 2.55 (3.24%) |
| Ex-Dividend Date | Jun 27, 2025 |
| Volume | 218 |
| Average Volume | 589 |
| Open | 78.24 |
| Previous Close | 77.98 |
| Day's Range | 77.83 - 79.00 |
| 52-Week Range | 70.58 - 90.81 |
| Beta | 0.82 |
| RSI | 56.02 |
| Earnings Date | Aug 19, 2025 |
About United States Steel
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial StatementsNews
Medtronic to announce financial results for its first quarter of fiscal year 2026
GALWAY, Ireland , Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, f...
More Downside For Medtronic Stock?
Medtronic (NYSE:MDT), which is renowned for inventing the world's first battery-operated implantable pacemaker, has over time earned respect as a worldwide leader in medical technology and has created...
Medtronic: Diabetes Business Spin-Off Key To Overcoming Stagnation
If You'd Invested $1,000 in Medtronic (MDT) Stock 5 Years Ago, Here's How Much You'd Have Today
Spoiler: Your money wouldn't have grown much, but it might grow much faster in the years to come.
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to i...
Medtronic: Growth Challenges Persist
Medtronic shares snapped six-session winning streak
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences’ (NYSE: EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by ...
Court Nixes Jury Award Over Medtronic's Heart Valve Infringement Claim
A federal appeals court has sided with Medtronic Plc (NYSE: MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent...
Medtronic gets EU nod for MiniMed 780G System
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
GALWAY, Ireland , July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the...
Medtronic wins appeals to avoid $106.5M patent verdict
Got Their Backs: How Medtronic Brings Spine Surgeries to Kids
Medtronic has worked with nonprofit SpineHope to give more than 200 children life-changing medical treatment since 2008 NORTHAMPTON, MA / ACCESS Newswire / July 16, 2025 / As kids go, Monica Santamari...
Medtronic Stock Is Climbing Friday: What's Going On?
On Wednesday, the Centers for Medicare & Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and...
Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'
When it comes to artificial intelligence stocks , there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood. One of Wood's favorite AI stocks has been criticized by ...
A Look at How Healthcare Technology Is Improving Wildlife Conservation
Medtronic CEO, Geoff Martha, recently visited the Wildlife Science Center to see how health tech is advancing conservation science and helping to improve quality of life in wolves NORTHAMPTON, MA / AC...
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
GALWAY, Ireland , July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of ...
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook
Merit Medical Systems Inc. (NASDAQ: MMSI) announced a leadership transition on Monday, naming Martha Aronson as its next President and CEO, effective October 3, 2025 . Current CEO Fred Lampropoulos ,...
This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap'
ForSight Robotics , an Israeli startup aiming to automate cataract and eye surgery, announced Tuesday that it raised $125 million to expand its precision robotics platform, Oryom. The round was led by...
Medtronic: Cash Flow Strength Balanced By Execution Risks
Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
Initiate Medtronic with Strong Buy, $161 PT, citing a structural margin inflection from Diabetes spin-off and robust innovation pipeline (120+ approvals). Street underestimates FY27 margin/EPS upside ...
Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
I reiterate my buy rating on Medtronic, driven by solid fundamentals and an attractive valuation, despite less upside versus prior estimates. Medtronic continues to deliver steady revenue growth, robu...
Medtronic Board appoints Dr. Joon Lee as a new director
GALWAY, Ireland , June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory He...
Looking Into Medtronic's Recent Short Interest
Medtronic's (NYSE: MDT) short percent of float has fallen 42.06% since its last report. The company recently reported that it has 7.88 million shares sold short , which is 0.62% of all regular shares...